Isoptin

Verapamil, the active ingredient in Isoptin, is a calcium channel blocker presented as an intravenous solution for intravenous use. It is used to manage high blood pressure, chest pain and certain rapid heart rhythms in adult patients. GNH USA supplies Isoptin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isoptin (verapamil) is employed in cardiovascular conditions that involve excessive calcium‑mediated contraction. - Hypertension: lowers blood pressure by relaxing vascular smooth muscle. - Angina pectoris: reduces myocardial oxygen demand and improves coronary blood flow. - Supraventricular tachyarrhythmias: slows conduction through the AV node to control heart rate.

Verapamil may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness or light‑headedness: especially on standing. - Peripheral edema: swelling of the ankles or feet. - Constipation: reduced bowel motility. - Flushing: transient warmth and redness. - Nausea: occasional upset stomach.

Serious or Rare Side Effects: - Bradycardia: markedly slow heart rate. - Heart block: impaired electrical conduction. - Severe hypotension: dangerous drop in blood pressure. - Acute myocardial infarction: rare but possible. - Hepatic dysfunction: elevated liver enzymes. - Allergic reactions: rash, itching, or anaphylaxis.

Before initiating therapy with Isoptin, consider the following safety measures. - Cardiac function: assess for existing heart block or severe left ventricular dysfunction. - Blood pressure: monitor baseline and ongoing readings to avoid excessive hypotension. - Concomitant drugs: review for agents that also lower heart rate or blood pressure. - Renal or hepatic impairment: adjust monitoring as clearance may be affected. - Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Verapamil can alter the effects of several other medicines.

Major Interactions (Avoid): - Beta‑blockers: may cause profound bradycardia or heart block. - Digoxin: increased serum levels leading to toxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): raise verapamil concentrations.

Moderate Interactions (Monitor Closely): - Antihypertensives (ACE inhibitors, diuretics): additive blood‑pressure lowering. - Statins metabolized by CYP3A4 (e.g., simvastatin): may increase statin exposure. - Anticonvulsants (phenytoin, carbamazepine): may reduce verapamil effectiveness.